INTRODUCTION
The Leishmania donovani parasite is a protozoan that causes a severe, debilitating and often fatal disease called visceral leishmaniosis (VL) which is a public health problem in areas of Latin America,Although VL has received conside rable attention, efforts toward vaccination against leishmaniosis have focussed almost exclusively on localized cutaneous disease (reviewed by Handman 2001) . Upophosphoglycan (LPG) a glycoconjugate present on the surface of the Leishmanias expressed in promastigotes and amastigotes (Turco 1988 , McNeely & Doyle 1996 and reported to promote intracellular survival of these parasites, has been shown to protect mice and to elicit T-cell responses in infected mice (Handman & Mitchell 1985; McConvile, Bacic, Mitchell & Handman 1987; Russell & Alexander 1988; Elhay, Kelleher, Bacic , McConville, Tolson Pearson & Handman 1990 ) and humans (Kemp, Theander, Handman, Hey, Kurtzhals, Hviid, Srren- Russell & Coutinho 1991) . Studies have shown that the lymphocyte proliferation is associated with the protein component and not the glycan otLPG (Jardim, Tolson, Turco, Pearson & Olafson 1991; Russo, Turco, Burns & Reed 1992) . Studies in our laboratory have shown that LPG is an excellent candidate as a transmission blocking vaccine against Leishmania major infections (reviewed Tonui 1999; Tonui, Mbati, Anjili, Orago, Turco, Githure & Koech 2oo1a, b) . In these studies, sand flies which fed on BALBlc mice immunized with L. major-derived LPG (Tonui et al. 2001a) or monoclonal antibodies raised against LPG (Tonui, Ngumbi, Mpoke, Orago, Mbati, Turco & Mkoji 2003) showed that parasite development was inhibited at the log phase (procyclic) of the parasite. There was also a marked reduction in the numbers of metacyclic promastigotes developing , leading to reduced transmission of L. major to naive BALB/c mice (Tonui at al. 2001 b) . These results prompted us to further evaluate LPG as a vaccine candidate in leishmaniosis. Our goal has been to develop a vaccine that can be used both to reduce transmissible infections within the sand fly and disease severity within the mammalian host.
MATERIALS AND METHODS

Isolation of Upophosphoglycan
The LPG antigen was extracted from L. donovani promastigotes, purified and quantitated by phosphate analysis as has previously been described (McConvile et al. 1987; Orlandi & Turco 1987) . Lyophilised LPG was dissolved to desired concentrations in sterile phosphate buffered saline before vaccinations.
Animals and vaccination protocol
BALBlc mice and Syrian golden hamsters (Mesocricetus auratus) used in this study were obtained from the Kenya Medical Research Institute's (KEMRI) animal house and maintained under conventional conditions. A group of 15 hamsters, matched by sex, were each immunized by three subcutaneous (s.c.) injections of 20 IJglmt LPG mixed with 50 jJt BCG (Pasteur Merieux, Lyon, France) . Injections were given at 2-week intervals (Ingonga, Mbati, Anjili, Mutani, Wishitemi, Odongo, Robert & Githure 1996) .
Another group of 15 hamsters, also matched by sex were used as controls. Five of these animals received 50 IJt BCG alone and five others received phosphate-buffered saline (PBS) alone. The last five of this group remained naive.
Vaccination of BALBlc mice was done as has previously been described (Handman, Symons, Balwia, Curtis & Scheerlinck 1995) . Briefly, 15 mice aged 6-8 weeks, matched by sex , were immunized intraperitoneally (i.p.) three times every 2 weeks with 10 IJglmt of purified LPG mixed with 50 jJt of BCG as an adjuvant. Another group of 15 mice were used as controls. Five of these animals received 50 jJt BCG alone and five others received phosphate-buffered saline (PBS) alone. The remaining five of this group remained naive. All animals were weighed weekly.
Two weeks after the last immunization , all animals were bled individually for sera used for testing humoral responses and divided into two groups: one group was used to examine T-cell responses to LPG antigen while the other group was challenged by inoculation of live L. donovani.
Assessment of delayed-type hypersensitivity (DTH) responses
One week after the third immunization, five animals from each group were selected at random and challenged intradermally in the left hind footpads with 5 jJg of LPG antigen. This amount of antigen had been determined in preliminary studies to be the minimum for OTH elicitation. The degree of skin induration was measured after 72 h, and those above 5 mm in diameter were recorded as positive (Yang, Rogers & Liew 1991) .
Humoral responses
Enzyme-linked immunosorbent assay (ELISA) was used to determine for antibody levels present in the serum of immunized animals (Voller, Bartlett & Bidwell 1976) . Briefly, 100 IJ{ of 10 jJg of LPG antigen was used for coating U-well polyvinyl chloride plates ovemight. After washing with PBS-{0.05%), Tween 20 and blocking with boiled casein, serial dilutions of sera were added to the plates and incubated at Lymphocytes isolated from spleens from two of the BALBlc mice in each group adjusted to a final concentration of 2 x tOG /m( in 100 ~t complete RPMI 1640 medium were stimulated with 20 ~g LPG. Control wells received the same number of cells plus complete RPMI 1640 only. Cultures set up in triplicates, were incubated at 37°C in a humidified atmosphere containing 5 % CO 2 , Cuhure supernatants were collected from the wells after 48 h of stimulation, and the concentrations of IFN-y and IL-4 in culture supernatants were determined by ELISA. Protocols outlined in the BD Pharmingen's manual were followed. Briefly, polystyrene micro-ELISA plates (Dynatech Laboratories, Sussex, UK) were coated overnight with 50 j..I( of a 2-j..Iglmt concentration of capture monoclonal antibody to rat anti-mouse IFN-y or IL-4 using (80 Pharmingen) diluted in bicarbonate buffer, pH 9.6. Plates were washed twice with Elisa solution consisting of 0.05% Tween 20 diluted in PBS and blocked with a blocking buffer consisting of 0.1 % Tween 20 and 3 % bovine serum albumin diluted in borate buffered saline for 2 h at room temperature. The plates were washed again twice, 50 j..I( per well standards and samples diluted in 0.05 % foetal bovine serum in PBS were added followed by incubation overnight
at 4°C. Plates were washed again four times and diluted biotinylated rabbit anti-mouse IFN-y or IL-4 detection poJyclonal antibodies added. Plates were incubated for 45 min at room temperature and washed again six times with Elisa wash. Diluted avidin-peroxidase (Sigma®) was added and incubated for 30 min at room temperature. Finally the plates were washed eight times with Elisa wash and 100 jJt of diluted TMB (TMB Peroxidase Development System, Kirkegaard & Perry, MD, USA) added. The colour reaction was stopped by adding 50 jJ( per well of sulphuric acid (1 :7 dilution) and read at 450-650 A. dual wave lengths.
Flow cytometry
For T and B cell analyses, respectively, phycoerythrin-conjugated hamster anti-mouse CD3 monoclonal antibody (Becton Dickinson or 80, USA) and fluorescein-conjugated hamster anti-mouse Ly-5 (B220) (BD, USA) was used. Briefly, 50 ~I of whole blood from immunized groups and the controls were loaded into a tube containing 2 jJi FITC anti CD3 or CDR 451B2oo labelled monoclonal antibodies. The mixture was incubated at room temperature for 30 min and 2 m( of lysis solution added. Following incubation for 10 min at room temperature, the cells were centrifuged at 1500 rpm {800 {/J for 5 min and washed twice with PBS. Finally, fluorescence was monitored by flow cytometry on a fluorescence-activated cell sorter (BD, Heidelberg, Germany) counting to 000 cells per sample.
Challenge of vaccinated animals
The L. donovani (strain NLB-065) used was isolated from a kala-azar patient prior to the start of these experiments. Parasites were cultured as has been previously been described (Mbati, Anjili, Lugalia, Mwanyumba, Tonui, Robert & Githure 1995) . Both immunized and control animals were each challenged with 10S virulent L. donovan; metacyclic promastigotes in 0.1 ml PBS i.p. (Mbati, Abok, Orago, Anjili, Kagai, Githure & Koech 1994) . Animals were left in order to allow the infection to develop for a period of at least 6 months. At the end of the experiments, their spleens, livers, and bone marrow were removed and cultured for parasites. Parasite loads in these tissues were determined using the methods of Chulay & Brycesson (1983) .
Statistical analYSis
Student's t test was used in comparative analysis and a P value of P < 0.05 was considered significant. and BALB/c mice , respectively, there were no noticeable side effects both locally and system ically; implying that the molecule was safe at th is dosage level. Delayed type hypersensitivity responses were positive for all vaccinated animals , with the mean skin indu ration of 8.38 and 5.996 mm in diameter for hamsters and BALB/c mice, respectively (Fig . 1) . Animals in control groups BGG or PBS were not tested for DTH responses using LPG , to avoid any exposure to the antigen before challenge.
Antibody levels
Sera from hamste rs or mice immunized with LPG plus BGG tested by ELI SA revealed significant IgG responses to LPG antigen compared to animals inoculated with BGG alone or PBS (controls), indicating a successful imm unization (P < 0.05). LPG plus BGG-immunized hamsters showed average optical density (00) values of 0.640 whereas BGG and PBS-immunized controls showed an average of 0.149 and 0.061, respectively (Table 1) . LPG plus BGG-immunized mice showed 0 0 values of 0.708 whereas BGG or PBS controls showed 0.124 and 0.065, respectively.
In vitro lymphocyte proliferation to LPG In Fig . 2 and Fig. 3 the counts per min following stimulation of lymphocytes from vaccinated animals or their controls are represented. Data showed that cells count from animals immunized with LPG plus BGG was higher compared to those of their control animals previously immunized with BGG or PBS .
These data suggests that cells from an imals vaccinated with LPG plus BGG showed higher proliferation on re-stimulation with the LPG antigen.
Secretion of Interferon gamma (IFN--r) and Interleukin 4 (IL-4)
In order to assess antigen-specific IFN-y or IL-4 production , lymphocytes from BALB/c mice immunized with LPG plus BeG, BeG or PBS were stimulated with the LPG antigen for 48 h. Resu lts showed that supernatants from animals previously immunized with LPG plus BeG expressed significantly higher IFN-y levels compared to BGG or PBS controls (P < 0.05). On the other hand, animals immunized with BGG alone or PBS expressed high levels of IL-4 compared to LPG plus BeG group (Fig. 4) . Results of hamster immunizations are not featu red due to the fact that the reagents for the hamster models are not available.
B and T-cell phenotypes
Fluorescence activated cell sorter analyses indicated no significant differences in terms of T and Bcell populations between animals immunized with LPG plus BeG and those given BeG alone or the PBS controls (Table 2) .
Protection conferred by vaccination with LPG
Mean body mass
In these experiments, mean body mass as a criterion for monitoring wasting and emaciation following challenge infection was used. The mean body mass of immunized animals and their controls were donovan; had average but higher mass loss com· pared to BGG·immunized controls (Fig. 5) . The PBS controls showed gradual loss of mass, which was the highest in the three groups. In all the experi· mental groups, wasting , emaciation and eventually death of animals accompanied mass loss. The ini· tial mass increase in all the experimental animals was a result of splenomegaly due to infection rather that chronological factors (data not shown). Over· all, the mean mass loss in LPG plus BGG , BGG and PBS controls were 5.5, 4 and 6 g, respectively.
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Unlike hamsters, BALBlc mice showed an increase in body mass throughout the experiment. The group, which had received PBS alone , showed the highest mean mass gain compared to the BCG and the LPG plus BGG immunized groups. The LPG plus BGG group showed an average increase in mass throughout the experiment. The BGG group showed the highest increase in body mass, which were sta· tistically significant, compared to the control and the LPG plus BGG groups (P < O.05) . Overall , there was an increase of 1, 2 and 4 g respectively for the PBS, LPG plus BGG and the BCG groups (Fig. 6 ) .
Spleen parasite loads
After 6 months the experiments were stopped and the remaining animals killed. At this stage all the hamsters from the BGG-immunized groups had died and only four animals from the LPG plus BGG and three from the PBS control groups had sur· vived. Surviving animals were killed and their spleens were cultured for parasites and touch smears were made on glass slides. Results showed that spleen biopsies from the dead and the sUlViving animals were enlarged and yielded para· sites in culture. Furthermore, there were no signifi· cant differences in the parasite loads in the spleen of all the sUlViving animals. All animals showed severe parasitaemia levels (4+) in their spleens.
At the end of experiments 9, 1 and 5 BALBlc mice survived in the LPG plus BCG. BCG and PBS groups, respectively. On sacrificing, five out of nine (55.5 'Yo) spleen biopsies from L. donovan; infected LPG·immunized BALB/c mice were negative for parasites, while all cultures from the PBS and BGG· treated mice yielded parasites (0 % negative). The parasite loads in LPG plus BGG·immunized mice were low (1+) whereas those of BGG and PBS showed an average of 3+.
DISCUSSION
Many studies have demonstrated the importance of T -celt responses in recovery and resistance to leishmaniosis. It is therefore of considerable impor· tance to use T ·cell responses to evaluate the immunostimulatory potential of Leishmania antigens (Russo et al. 1992 Handman & Mitchell 1985; McConvile et al. 1987) . Therefore, our study sought to determine whether such results could be extrapolated to visceral leishmaniosis caused by L. donovani using susceptible BALBlc mice and hamsters models.
In this study, the induction of cell-mediated immunity (CMI) following vaccination was determined by measuring delayed-type hypersensitivity, in vitro lymphocyte proliferation and gamma interferon (IFN-y) production . LPG plus BCG-immunized animals developed positive DTH responses, which are commonly used as an indication of resistance against the disease (Carvalho, Badaro, Reed, Jones & Johnson 1985; Gajewski, Schell, Nau & Fitch 1989; White & MacMahon-Pratt 1990; Kemp, Kurtzhals, Bendtzen, Poulsen, Hansen, Koech , Kharazmi & Theander 1993; Kemp 1997) . Lymphocytes from LPG plus BCG-immunized animals also proliferated on re-stimulation with the LPG antigen . This ability to induce proliferation was shown to be related to proteins associated with LPG , which enhance the antigenicity of purified LPG for human T -lymphocytes (Jardim et al. 1991 ; Mendonca et at. 1992) . In this study, supernatants from re-stimulated lymphocytes expressed high levels of IFN-r compared to IL-4 levels on re-stimulation with the LPG antigen. The production of high levels of IFN-y is also a characteristic of resistance and subsequently protection to Leishmania infections (Kemp 1997 ).
In our experiments, mean body mass as a criteria for monitoring wasting and emaciation , and parasite loads for disease severity following infection with L. donovani were used . Results showed that hamsters previously immunized with LPG plus BCG showed an average mass loss compared to the PBS controls. BCG-immunized hamsters, on the other hand, showed smaller mass loss compared to the LPG plus BCG or the PBS controls. In all the experimental groups, wasting, emaciation and eventually death of animals accompanied mass loss by the 511' 1 month. Surviving animals were killed and examination of their spleens showed high levels of para- 
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Other experiments have shown that LPG provided excellent protection to L. major infections in BALB/c mice (Handman & Mitchell 1985; McConvile et al. 1987; Russell & Alexander 1988) . Protection depended on the use of adjuvants such as Jiposomes or Corynebacterium parvum and on the integrity of the molecule. Not only was the watersoluble form of LPG lacking the glycosylphosphadidylinositol anchor not protective. but also it exacerbated the disease (Mitchell & Handman 1986) . A purified water-soluble form of LPG was used in our study and this may explain the low immunogenicity and the partial protection observed in immunized rodents. These results suggest that other adjuvants apart from BCG should be considered in the pursuit of increasing the immunogenicity of this molecule in vaccination studies. In conclusion, although vaccination with LPG plus BCG induced a Th1 response, which correlated with protection , the disease course was not altered in hamsters and therefore protection was low and not significantly different compared to that of the BCG or PBS controls. Since the LPG molecule shows the presence of correlates of protection, the results obtained in these experiments agree with other published reports (Hand man 2001) that it may be rewarding to re-evaluate the potential of LPG as a vaccine candidate in leishmaniosis.
